T-CELL ACUTE LYMPHOCYTIC LEUKEMIA
Clinical trials for T-CELL ACUTE LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new T-CELL ACUTE LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for T-CELL ACUTE LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Living Drug' trial targets aggressive blood cancers in kids and adults
Disease control Recruiting nowThis study is testing a new type of personalized cell therapy called CD5 CAR-T for people with T-cell cancers that have come back or not responded to other treatments. Doctors will modify a patient's own immune cells (or cells from a donor) to better target and fight the cancer. …
Matched conditions: T-CELL ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for incurable blood cancers: experimental CAR-T therapy enters trial
Disease control Recruiting nowThis study is testing a new type of personalized immune cell therapy, called CD5-CAR T cells, for people with aggressive T-cell blood cancers that have come back or not responded to standard treatments. The main goals are to find a safe and effective dose and to see if the therap…
Matched conditions: T-CELL ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Mar 02, 2026 15:28 UTC